XML 38 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 29, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Compensation Cost

The cost that has been charged against income for stock-based compensation is set forth below (in thousands):

 

 

Three Months Ended

 

 

 

March 29, 2024

 

 

March 31, 2023

 

Employee stock options

 

$

3,173

 

 

$

2,977

 

Restricted stock

 

 

28

 

 

 

67

 

RSUs

 

 

2,312

 

 

 

1,601

 

PSUs

 

 

685

 

 

 

1,106

 

Nonemployee stock options

 

 

141

 

 

 

314

 

Total stock-based compensation expense

 

$

6,339

 

 

$

6,065

 

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The Company recorded stock-based compensation costs in the following categories (in thousands):

 

 

 

Three Months Ended

 

 

 

March 29, 2024

 

 

March 31, 2023

 

Cost of sales

 

$

298

 

 

$

149

 

General and administrative

 

 

3,075

 

 

 

3,363

 

Selling and marketing

 

 

1,210

 

 

 

857

 

Research and development

 

 

1,756

 

 

 

1,696

 

Total stock-based compensation expense, net

 

 

6,339

 

 

 

6,065

 

Amounts capitalized as part of inventory

 

 

337

 

 

 

369

 

Total stock-based compensation expense, gross

 

$

6,676

 

 

$

6,434

 

 

Schedule of Unrecognized Compensation Cost, Non-Vested Stock-Based Compensation Arrangements

As of March 29, 2024, total unrecognized compensation cost related to non-vested stock-based compensation arrangements were as follows (in thousands):

 

 

 

March 29, 2024

 

Stock options

 

$

28,392

 

Restricted stock, RSUs and PSUs

 

 

43,614

 

Total unrecognized stock-based compensation cost

 

$

72,006

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.

 

 

 

Three Months Ended

 

 

 

March 29, 2024

 

 

March 31, 2023

 

Expected dividend yield

 

 

0

%

 

 

0

%

Expected volatility

 

 

59

%

 

 

60

%

Risk-free interest rate

 

 

4.16

%

 

 

3.96

%

Expected term (in years)

 

 

5.29

 

 

 

5.05

 

Schedule of Share-based Compensation, Stock Options, Activity

A summary of stock option activity under the Equity Plan for three months ended March 29, 2024 is presented below:

 

 

 

Stock
Options
(in 000’s)

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value
(in 000’s)

 

Outstanding at December 29, 2023

 

 

2,630

 

 

$

46.38

 

 

 

 

 

 

 

Granted

 

 

523

 

 

 

37.21

 

 

 

 

 

 

 

Exercised

 

 

(187

)

 

 

28.50

 

 

 

 

 

 

 

Forfeited or expired

 

 

(83

)

 

 

76.05

 

 

 

 

 

 

 

Outstanding at March 29, 2024

 

 

2,883

 

 

$

45.01

 

 

 

6.98

 

 

$

16,386

 

Exercisable at March 29, 2024

 

 

1,668

 

 

$

42.93

 

 

 

5.41

 

 

$

15,090

 

Schedule of Share-based Compensation, Restricted Stock, RSU and PSU Activity

A summary of restricted stock, RSU and PSU activity under the Equity Plan for the three months ended March 29, 2024 is presented below (shares in thousands):

 

 

 

Restricted
Stock

 

 

RSUs

 

 

PSUs

 

Unvested at December 29, 2023

 

 

14

 

 

 

401

 

 

 

56

 

Granted

 

 

 

 

 

415

 

 

 

390

 

Vested

 

 

 

 

 

(110

)

 

 

(24

)

Forfeited or expired

 

 

(4

)

 

 

(1

)

 

 

(4

)

Unvested at March 29, 2024

 

 

10

 

 

 

705

 

 

 

418